Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of

188Re 99mTc PSMA SPECT phosphine

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 22 01 2024
accepted: 29 04 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 6 6 2024
Statut: aheadofprint

Résumé

Benchtop

Identifiants

pubmed: 38844360
pii: jnumed.124.267450
doi: 10.2967/jnumed.124.267450
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Truc T Pham (TT)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom; truc.pham@kcl.ac.uk michelle.ma@kcl.ac.uk.

Ingebjørg N Hungnes (IN)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.

Charlotte Rivas (C)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.

Julie Cleaver (J)

Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.

George Firth (G)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.

Philip J Blower (PJ)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.

Jane Sosabowski (J)

Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.

Gary J R Cook (GJR)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.

Lefteris Livieratos (L)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.
Department of Nuclear Medicine, Guy's and St. Thomas' Hospitals NHS Foundation Trust, Guy's Hospital, London, United Kingdom; and.

Jennifer D Young (JD)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.
Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.

Paul G Pringle (PG)

School of Chemistry, University of Bristol, Bristol, United Kingdom.

Michelle T Ma (MT)

School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom; truc.pham@kcl.ac.uk michelle.ma@kcl.ac.uk.

Classifications MeSH